HCC
Hirtle Callaghan & Co’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $849K | Buy |
2,094
+94
| +5% | +$38.1K | 0.03% | 66 |
|
|
2025
Q1 | $995K | Buy |
+2,000
| New | +$995K | 0.04% | 67 |
|
|
2024
Q1 | – | Sell |
-685
| Closed | -$364K | – | 106 |
|
|
2023
Q4 | $364K | Buy |
+685
| New | +$364K | 0.02% | 78 |
|
|
2023
Q2 | – | Sell |
-1,106
| Closed | -$637K | – | 86 |
|
|
2023
Q1 | $637K | Sell |
1,106
-8,059
| -88% | -$4.64M | 0.03% | 59 |
|
|
2022
Q4 | $5.05M | Buy |
9,165
+4,520
| +97% | +$2.49M | 0.31% | 33 |
|
|
2022
Q3 | $2.36M | Sell |
4,645
-2,771
| -37% | -$1.41M | 0.17% | 46 |
|
|
2022
Q2 | $4.03M | Sell |
7,416
-416
| -5% | -$226K | 0.24% | 33 |
|
|
2022
Q1 | $4.63M | Buy |
7,832
+5,722
| +271% | +$3.38M | 0.22% | 33 |
|
|
2021
Q4 | $1.41M | Buy |
+2,110
| New | +$1.41M | 0.07% | 47 |
|
|
2014
Q3 | – | Sell |
-850
| Closed | -$100K | – | 624 |
|
|
2014
Q2 | $100K | Buy |
+850
| New | +$100K | 0.01% | 291 |
|